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Abstract
Background
There is paucity of data on risk factors for reduced fertility in low-income countries.
Objective
To investigate factors associated with fertility among women in rural north eastern
Tanzania.
Subjects and methods
A cohort of 1248 non-pregnant women was followed with urine pregnancy testing every third
month or more regularly if they reported a missed menstrual period. Pregnancy was con-
firmed with trans-abdominal ultrasound. Information regarding general health, socioeco-
nomic status and obstetric-gynaecological history was collected. Factors associated with
conceiving within 180 days were identified using multivariate logistic regression analyses.
Results
Among the 1248 women, 736 were followed for 180 days and 209 of these had an ultra-
sound confirmed pregnancy. During the follow-up period, 169/736 women were diagnosed
with urogenital infections, including suspected sexually transmitted or reproductive tract
infections, urinary tract infection, and vaginal candidiasis. Urogenital infections were signifi-
cantly associated with reduced odds of conceiving within 180 days (adjusted OR (AOR)
0.21, 95% CI 0.11–0.36). Being above 30 years of age was also negatively associated with
odds of conceiving (AOR 0.45, 95% CI 0.26–0.77). In contrast, women who recently
stopped using hormonal contraceptives (AOR 2.86, 95% CI 1.45–5.70) and women with low
socioeconomic status (AOR 1.56, 95% CI 1.04–2.33) were significantly more likely to
become pregnant within 180 days.
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Conclusion
Urogenital infection seems to be a major health factor associated with reduced chances of
conceiving. Considering the availability of effective treatment options for these diseases,
public health authorities should increase awareness of diagnostic tools in settings with lim-
ited resources in order to improve fertility.
Introduction
The World Health Organization (WHO) defines infertility as “A disease of the reproductive sys-
tem defined by the failure to achieve a clinical pregnancy after 12 months or more of regular
unprotected sexual intercourse” [1]. During the last three decades there has been an increasing
attention on infertility, and fertility is now mentioned in the reproductive rights defined by
WHO [2]. There is an increasing demand for assisted reproductive technology and research
defining the causes of infertility in high income countries (HIC) [3–5]. However, the causes of
infertility in low- and middle-income countries (LMIC) remain poorly defined [6]. In 2002, it
was estimated that approximately 186 million women in the reproductive age worldwide were
infertile defined as the number of ever married women with no birth the last five years [7].
Due to methodological challenges, an exact estimate of the number of women and couples suf-
fering from infertility is difficult to obtain, but most studies estimate the global infertility rate
to be around 10% [8–12]. In Sub-Saharan Africa infertility rates are higher with estimates
from 15% to 40% [9, 10, 13, 14].
The high prevalence of infertility in LMIC is a major healt concern due to limited availabil-
ity of treatment and the social, cultural, and economic consequences of infertility in these
regions [9, 14]. Women living in infertile relationships are at risk of experiencing domestic
violence, depression, social exclusion, stigmatization, polygamy [15, 16] and it can also dra-
matically influence the economic situation of families [12, 16].Furthermore infertility can pre-
vent young girls from gaining respect and status as a women in the eyes of the society, which
can catch them in a limbo between two stages of life [17].
Identifying factors associated with infertility is an essential step in establishing adequate
treatment and preventive strategies. Maternal age [18], smoking [19], alcohol abuse [20], geni-
tal infections [21, 22] and body mass index (BMI) [23] have been shown to affect fertility in
high income countries (HIC). However, there is a paucity of data on causes for infertility in
LMIC, where there is a considerably higher frequency of secondary infertility (inability to
become pregnant or to carry a pregnancy to a live birth following a previous pregnancy) [24].
A large older study concluded that infertility in Africa could be attributed to infections in 85%
of the cases, and that the majority of these infections were either sexually transmitted infec-
tions (STI) or infections acquired following delivery or illegal abortion [25].
The aim of the present study was to define factors associated with the chances of conceiving
among women in rural Tanzania. Identification of such factors may be an important step
towards implementing health- and socioeconomical actions to reduce infertility.
Methods
The study was part of the preconceptional and pregnancy cohort study “Foetal exposure and
Epidemiological Transition: the role of Anaemia in early Life for Non-Communicable-Dis-
eases later in life” (FOETALforNCD) conducted in 48 rural and semi-urban villages of
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Korogwe and Handeni Districts, Tanga Region, North-east Tanzania from July 2014 until
December 2016. The FOETALforNCD study consisted of two sub-studies: a preconceptional
and pregnancy cohort study following women before pregnancy as well as throughout preg-
nancy until delivery if they conceived, and a pregnancy cohort study following women who
were< = 14 weeks pregnant at enrolment and followed until delivery. We here present data
on the preconceptional part of the study.
Inclusion and exclusions criteria for FOETALforNCD
Non-pregnant women were enrolled from July 2014 until December 2015. The preconcep-
tional follow-up period was from July 2014 to March 2016 and women found to be pregnant
before the 31st of March 2016 were enrolled in the pregnancy part of the study. Inclusion crite-
ria in the preconceptional part were: age 18–40 years, not using modern contraceptive meth-
ods except for condoms, not having a child of less than nine months of age, not having tried
unsuccessfully to conceive for more than two consecutive years (perceived as sub-fertile), a
negative urine pregnancy test (UPT) (HCG, sensitivity of 25 miU/ml HCG, Vista Care Com-
pany, Shandong, China), living in an accessible area, and willingness to attend all project activ-
ities including giving birth at Korogwe District Hospital if conceiving during the study period.
There were no additional exclusion criteria.
Enrolment
Upon enrolment, a comprehensive questionnaire (S5, S6 and S7 Tables) was filled out includ-
ing detailed information on demographic data, socioeconomic status, tobacco, alcohol, and
caffeine consumption, usage of family planning, gynaecological diseases, menstrual cycle pat-
tern, obstetric history, and medical history including known chronic anaemia, diabetes melli-
tus, hypertension, kidney disease, cancer, or HIV, and recent anaemia or malaria. A medical
examination was conducted including blood pressure (r-champion N, Rudolf Riester, Jungin-
gen, Germany, automated) and anthropometric measurements. Anthropometric measure-
ments included weight measured while barefooted and wearing light clothes (precision 0.1kg,
digital weighing scales, Seca GmbH & Co. KG, Hamburg, Germany), height (stadiometer, pre-
cision 1 cm, Seca GmbH & Co. KG., Hamburg, Germany), and mid-upper arm circumference
(MUAC), waist circumference measured just above the iliac crest in the horizontal plane, and
hip circumference measured at the point yielding the maximum circumference over the but-
tocks, all using a standard measuring tape to the nearest 0.1 cm [26]. Body mass index (BMI)
in kg/m2 was categorized as underweight (<18.5), normal (18.5–24.9), overweight (25.0–29.9)
and obese (� 30.0) [27]. Normal cycle length was defined as 25–34 days [28]. Hypertension
was defined as systolic blood pressure�140 mmHg and/or diastolic blood pressure�90
mmHg observed at two different occasions, or as known hypertension before enrolment and
on antihypertensive medication. To enable immediate treatment, point-of-care diagnostics
were used at enrolment to capture anaemia (HemoCue HB 301 analyzer, HemoCue AB,
Angelholm, Sweden), diabetes (HemoCue Glucose 201 analyzer, HemoCue AB, Angelholm,
Sweden), malaria (rapid diagnostic test for malaria, ParaHIT, Span Diagnostics, Gujarat
India), HIV if the women consented (Rapid diagnostic test for HIV, Alere Determine HIV-1/2
test kit, Alere LTD, Stockport, UK, and confirmed using a Unigold test kit, Trinity Biotech plc,
Wicklow, Ireland), and signs of urinary infections (Urine dipstick, Combiscreen 7, Alere, Mas-
sachusets, USA). Diagnostics (point-of-care or in centralized laboratory) for other sexually
transmitted and reproductive tract infections (STI/RTI) were not available. However, women
with relevant gynaecological symptoms were offered gynaecological ultrasound and a gynaeco-
logical examination by the study physicians (CS and OA). Furthermore, 15 mL of venous
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blood was collected in ethylenediamine tetra acetic acid (EDTA) coated and plain serum tubes
and transported at 2–8˚C to the National Institute for Medical Research (NIMR) Korogwe
Research Laboratory and processed within two hours of sample collection. In the NIMR Kor-
ogwe Research Laboratory, full haematological blood picture, HbA1c, and C-reactive protein
(CRP) were measured using Sysmex KX-21N haematological analyser (Sysmex Corporation
Kobe, Japan) and Afinion AS 100 analyser (Axis Shield PoC, AS, Oslo Norway), respectively.
Diabetes mellitus were diagnosed as random blood sugar > 11.1 mmol/L at two different
consultations, or fasting blood glucose >7 mmol/L, or HbA1c >6.5% (Afinion AS 100 analy-
ser, Axis Shield PoC, AS, Oslo Norway). Anaemia (hgb concentration <12 g/dL) was treated
with combination tablets of FeFo (200 mg ferrous sulfate (~ 43 mg elemental iron) and 400 μg
folate per day (Ferrolic–LF, Laboratory and Allied LTD, Mombasa, Kenya) or Hemovi multivi-
tamin syrup containing 200 mg Ferrous sulfate, 0.5 mg B6, 50 μg B12, 1.5 mg Folic acid and
2.33 mg zinc sulphate per 5mL (Shelys Pharmaceuticals, Dar es Salaam, Tanzania). Malaria
was treated with oral Artemether-lumefantrine (Lumartem 20mg/120mg (CIPLA LTD, Patal-
ganga, India). HIV seropositive women were referred to the governmental Care and Treat-
ment Clinics and managed according to national guidelines. Urinary tract infections (UTI,
clinical symptoms and leucocytes and/or nitrite on urine dipstick) were treated with amoxicil-
lin 500 mg three times a day for three days (North China Pharmaceuticals Group Formulation
Company Ltd. Shijazhuang, China) and suspected vaginal candidiasis (vaginal itching and
whitish curd-like vaginal discharge) with clotrimazole vaginal suppository 100 mg daily for 5
days (Laboratory and Allied LTD, Mombasa, Kenya). Other suspected genital infections were
managed with syndromic treatment with ciprofloxacin 500 mg once, doxycycline 100 mg
twice a day for 7 days, and 2g metronidazole once (all from Astra lifecare, Ahmedabad, India).
Follow up
After enrolment, the women were followed every third month with UPT. Women were also
encouraged to report before their scheduled visit if they suspected to be pregnant. From
March 2015, to avoid overlooking any pregnancies, ultrasound was performed if a menstrual
period was missed disregarding a negative UPT. If UPT positive and/or if suspecting to be
pregnant, transabdominal ultrasound were performed (5–2 MHz abdominal probe, Sonosite
TITAN and Sonosite Turbo, US High resolution, Sonosite, Bothell, WA, USA). Gestational
age was estimated using crown rump length in the 1st trimester [29] or head circumference in
the 2nd trimester [30] if pregnancy was confirmed. Haemoglobin (hgb) level concentration,
urine dipstick, and anthropometric measurements were routinely repeated, and all other tests
were repeated based on presented symptoms and at the clinician´s discretion. Any diseases
diagnosed at follow up were treated as described under Enrolment.
Definition of women eligible for inclusion in analyses on fertility
Only women who were confirmed to be truly preconceptional at the time of screening were
included. This entailed either 1) having negative UPT at all visits and that a pregnancy was
never confirmed with ultrasound, or 2) having a positive UPT at a follow-up visit combined
with ultrasound confirming she conceived after enrolment. Women who started using modern
family planning, were considered to enter menopause, or withdrew consent during the pre-
conceptional follow-up period were excluded. Finally, the design of the FOETALforNCD
study resulted in enrolment at different time points, this gave rise to different follow-up peri-
ods, since preconceptional follow-up ended by March 2016 for all enrolled women disregard-
ing the time-point of enrolment. To equalize the probability of becoming pregnant for all
women included in the present analyses, only women followed for at least 180 days were
Urogenital infections and fertility
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considered. Fertility was analysed as a binary outcome defined as having either a clinical preg-
nancy confirmed with ultrasound or not conceiving within 180 days of follow-up. Women
who conceived after the 180 days were kept in the “not conceived” group in all analysis. Bio-
chemical pregnancies (positive UPT, never confirmed with ultrasound) were excluded.
Ethical considerations
Ethical clearance was granted by the Medical Research Coordinating Committee of the
National Institute for Medical Research (reference number NIMR/HQ/R.8a/Vol. IX/1717).
Village leaders and community members were explained about the study followed by house-
to-house sensitization meetings where couples were explained about the study before the
women were invited to the nearby health post for screening and enrolment. Written informed
consent (or thumbprints of illiterate women) was obtained from all women prior to enrol-
ment. All procedures were conducted in accordance with the Declaration of Helsinki and
Good Clinical and Laboratory Practice. Permission to publish has been given by the National
Institute For Medical Research n Tanzania.
Statistics
Statistical analyses were performed using “R” (R- studio, version 1.1.38). The approach aimed
at revealing important explanatory factors to the binary fertility response variable. A variant
set of explanatory variables were evaluated including categorical and continuous factors. The
continuous variables were analysed as continuous as well as categorized. The categorization
was done in clinically relevant groups in order to facilitate detection of possible non-linear
relations and to facilitate comparison to clinical literature. An initial univariate analysis was
conducted in search of factors with correlation to pregnancy. Contingency tables were created
between categorical factors and the response variable and tested for dependence using Fisher’s
Exact Test. Students t-test was used for continuous variables being normally distribuated (hgb,
hgb change during study, menstrual cycle length and BMI) and Mann-Whitney U test for con-
tinuous variabels not normally distributed (age and parity). Variables having a p-value<0.2 in
the univariate analyses were included in the initial multiple logistic regression model. Further-
more, variables known to be biologically plausible factors associated with fertility (BMI, cur-
rent use of contraception, gynaecological diseases, previous abdominal operation) were also
included in the multivariate model disregarding the result in the univariate analyses. Based on
this a logistic regression model was initially fitted to a manually curated set of explanatory vari-
ables. We then performed further model selection through backwards step-wise elimination of
variables by comparing the relative quality of candidate models using the Akaike Information
Criterion (AIC). AIC estimates the quality of a model by evaluation the goodness of fit against
model complexity. Between two equally performing models, AIC penalizes the model of higher
complexity (more explanatory variables) relative to the simpler model [31]. We chose the
model minimizing AIC using the step algorithm implemented in R. In order to apply such
model selection, the full model was fit to only complete samples across the included variables.
The final model was fit to the data of 669 women. A p-value <0.05 was considered statistically
significant. In order to test the robustness of the model on 180 days follow-up, models for 90
and 360 days follow up was also fitted. (S1 Table).
Results
A total of 2629 women were screened, 1415 women were enrolled and 1227 women were eligi-
ble for analyses (Fig 1). Among the 1227 women, 736 women were followed for at least 180
Urogenital infections and fertility
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days, and among these 209 (28%) women conceived. The Grouped characteristics of the 736
women are shown in Table 1.
There were more women represented in the groups of 18–25 years and of 35–40 years than
in the middle age groups. The majority were living with their partner. Educational level was
low with only 13.9% having completed secondary school or beyond (Table 1). Lifestyle factors
can affect fertility, but the effect of caffeine intake, alcohol and smoking were not investigated
due to low daily exposure level in the study population: Only five enjoyed more than one small
Coca-Cola, 14 had one or two cups of coffee, and 15 had three or more cups of tea. 31 women
drank alcohol, of which only 5 consumed more than 5 per week. Only two smokers were iden-
tified in the study.
According to BMI, the majority were normal weight, and the remaining was primarily
overweight or obese. In total, 84.3% reported a normal menstrual cycle and only few women
(2.9%) had a gynaecological disease diagnosed at enrolment or during follow-up, or had a pre-
vious abdominal operation (8.8%). A large proportion of the women had anaemia (36.2%).
Urogenital infections were also prevalent in the cohort: at enrolment or during a follow up
visit, 29 had a suspected STI/RTI, 98 had suspected vaginal candidiasis, and 86 had an UTI.
HIV and malaria were also present (34 women and 85 respectily). Use of contraceptives before
enrolment was common, and 28.8% were still using either condom or traditional contracep-
tion (periodic abstinence or withdrawal) at enrolment (Table 1).
Factors associated with fertility–univariate analysis
Increasing age, parity <1 or > = 5, infection with HIV, and urogenital infections were signifi-
cantly more prevalent among women who did not conceive. Recent termination of hormonal
contraceptives and living with a partner were more common among women who conceived.
There was a trend towards poor socioeconomic status measures, such as educational level
below secondary school, not having a corrugated iron roof, and working in business, as a
farmer, or in a service job, were more common among women conceiving.
A number of variables not included in Tables 1 and 2 were also tested and not found signifi-
cantly associated with conceiving (S2 Table). These included other anthropometric measure-
ments, other socio-economic factors, male factors (age, education, religion), diabetes mellitus,
and hypertension. There was no significant association between conceiving and hgb at enrol-
ment or change in hgb during the follow-up period (hgb at enrolment: difference between the
two groups: -0.06 g/dl, CI 95% -0.31 to 0.18, p = 0.62; change in hgb during follow-up period:
difference between the two groups: 0.14 g/dl, CI 95% -0.51 to 0.22, p = 0.43).
Factors associated with fertility–multivariate analysis
To assess the ability of different conditions or factors to predict whether a woman became
pregnant during follow-up data was fitted to a multivariate logistic regression model (Table 3).
Having a urogenital infection significantly decreased the odds of conceiving (adjusted Odds
Ratio (AOR) 0.21, 95% CI 0.11–0.36, p-value <0.001).
Age was associated with a decreased fertility for the age group 30–35 (AOR 0.45, 95% CI
0.26–0.77, p-value = 0.004) and 35–40 (AOR 0.43, 95% CI 0.26–0.71, p-value = 0.001) com-
pared to the reference group of age 18–24. Living in house without a corrugated iron roof
(indicating a low socioeconomic status in this population) increased the chance of conceiving
(AOR 1.56, 95% CI 1.04–2.33, p-value 0.04). Women who had stopped using hormonal
Fig 1. Flowchart of inclusion in study.
https://doi.org/10.1371/journal.pone.0210421.g001
Urogenital infections and fertility
PLOS ONE | https://doi.org/10.1371/journal.pone.0210421 January 10, 2019 7 / 16
Table 1. Characteristics of 736 women.
Characteristic Interval N-total n (%)
Age 18–25 731 218 (29.8)
25–30 153 (20.9)
30–35 154 (21.1)
35–40 206 (28.2)
Partner status Living with partner 731 546 (74.7)
Partner–not living together 87 (11.9)
No partner 98 (13.4)
Education Non 736 72 (9.8)
Primary school partially 562 (76.4)
Secondary school and higher 102 (13.9)
Job Professional 736 12 (1.6)
Business 103 (14.0)
Farmer 470 (63.9)
Service 27 (3.7)
House wife 108(14.7)
Student 16(2.2)
House roof Corrugated iron 736 528 (71.7)
Not corrugated iron 208 (28.3)
BMI <18.5 725 54 (7.4)
18.6–24.9 438 (60.4)
25–29.9 148 (20.4)
>30 85 (11.7)
Parity Nullipara (0) 734 103 (14,0)
Primipara (1) 132 (18.0)
Multipara (2–4) 373 (50,8)
Grand multipara (5+) 124 (16.9)
Previous extra-uterine pregnancy 736 5 (0.7)
Length of menstrual cycle Short 693 25 (3.6)
Normal 584 (84.3)
Long 84 (12.1)
Gynecological diseases� 736 21 (2.9)
Abdominal operations�� 735 65 (8.8)
HIV seropositive 600 34 (5.7)
Malaria during study 736 85 (11.5)
Urogenital infections during study��� 736 169 (23.0)
Hgb at enrolment (g/dL) <9 736 19 (2.6)
9–11.9 247 (33.6)
Contraception before study 736 586 (79.6)
Hormonal contraception before study 736 495 (67.3)
Traditional contraception before study 736 278 (37.8)
Condom usage before study 736 178 (24.2)
Termination of hormonal contraception <3 months 736 58 (7.9)
3–6 months 68 (9.2)
6–12 months 77 (10.5)
>12 months 202 (27.4)
Never used 241 (32.7)
Used, term. date unknown 90 (12.2)
(Continued)
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contraceptives within the last 3 months had significantly higher likehood of becoming preg-
nant than women with no previous use of hormonal contraception (AOR 2.86, 95% CI 1.45–
5.70, p-value = 0.0025). Women living with a partner were significantly more likely to become
pregnant than women who reported no current partner (AOR 3.55, 95% CI 1.84–7.39, p-
value = 0.0003).
Urogenital infections were defined as suspected STI/RTI, suspected vaginal candidiasis, or
UTI. When analysed as separate entities UTI and candida were significantly associated with
reduced change of conceiving (OR 0.33, CI95% 0.15–0,68, p-value<0.001 and OR: 0.21,
CI95% 0.086–0.45, p-value<0.001, respectively). Eventhough STI/RTI did not show a signifi-
cant association (OR: 0.68, CI95% 0.19 1.7, p value = 0.51; possibly due to the relative few sus-
pected cases) this variable was retained in the final model since STI/RTI is suspected to have
an effect on fertility.
To test the robustness of the conclusions, we performed two variations of the analyses: 1)
We considered a follow up period of 90 days and 360 days, respectively (S1 Table). In both
models urogenital infections had a significant effect on the likelihood of conceiving. 2) We rea-
nalysed the data as continuous variables for hgb, age, menstruation cycle length, parity, body
mass index (S3 Table). This alternative model was constructed with the exact same selection
approach described in the method section and shown in Table 3 and resulted in the same
conclusions.
Discussion
The effect of urogenital infections
Despite treatment being instigated for any suspected infection, the presence of urogenital
infections was associated with a marked decrease in chance of conceiving during a follow-up
period of 180 days. Sexually transmitted infections (STI) are a known cause of secondary infer-
tility, as well as a known cause of morbidity in LMIC [24, 32, 33]. In Tanzania, previous studies
have reported a 43–64% prevalence of STIs [34–36]. However, in this study area, as well as in
the rest of rural Tanzania, facilities for bacteria cultivation or PCR diagnosis are not available
and the diagnostic possibilities for STIs, RTIs, and vaginal candidiasis are limited to anamnes-
tic questions and urine dipsticks. To minimize the risk of misclassification, we therefore
Table 1. (Continued)
Characteristic Interval N-total n (%)
Termination of traditional contraception <3 months 736 7 (1.0)
3–6 months 11 (1.5)
6–12 months 15 (2.0)
>12 months 41 (5.6)
Never used 458 (62.2)
Used, term. date unknown 34 (4.6)
Still using 170 (23.1)
Current use of contraception ���� 736 212 (28.8)
N-total is the total number of women with available answers in each category. n is the number of cases.
� Gynecological diseases: fibroma, ovarian cysts, or specifics unknown to the patient.
��Abdominal operations: for extra uterine pregnancies, caesarian sections, or appendicitis.
��� Urogenital infections include suspected sexual transmitted/reproductive tract infections, urinary tract infections,
and suspected vaginal candidiasis
���� Current us of contraception: Condom or traditional contraception
https://doi.org/10.1371/journal.pone.0210421.t001
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Table 2. Factors affecting the chance of conceiving within 180 days.
Characteristic Interval N total N (%)
Non preg.
N total N (%)
Pregnant
p-value
Age 18–25 523 143 (27.3) 208 75 (36.1) 0.03�
25–30 105 (20.1) 48 (23.1) (23.735/208
)
30–35 115 (22.0) 39 (18.8)
35–40 160 (30.6) 46 (22.1)
Partner status Living with partner 523 369 (70.1) 208 177 (85.1) <0.001���
Not living with partner 69 (13.2) 18 (8.7)
No partner 85 (16.3) 13 (6.3)
Education None 527 57 (10.8) 209 15 (7.2) 0.06
Primary school partial/complete 390 (74.0) 172 (82.3)
Secondary school and higher 80 (15.2) 22 (10.5)
Job Professional 527 10 (1.9) 209 2 (1.0) 0.06
Business 72 (13.7) 31 (14.8)
Farmer 332 (63.0) 138 (66.0)
Service 17 (3.2) 10 (4.8)
Housewife 80 (15.2) 28 (13.4)
Student 16 (3.0) 0 (0)
House roof Corrugated iron 527 388 (73.6) 209 140 (67.0) 0.08
Not corrugated iron 139 (26.4) 69 (33.0)
BMI <18.5 517 41 (7.9) 208 13 (6.3) 0.64
18.6–24.9 310 (60.0) 128 (61.5)
25–29.9 109 (21.1) 39 (18.8)
>30 57 (11.0) 28 (13.5)
Parity Nullipara (0) 523 82 (15.7) 209 21 (10.0) 0.006��
Primipara (1) 88 (16.8) 44 (21.1)
Multipara (2–4) 250 (47.8) 123 (58.9)
Grand multipara (5+) 103 (19.7) 21 (10.0)
Previous extra-uterine pregnancy 527 4 (0.8) 209 1 (0.5) 1
Length of menstrual cycle Short 501 22 (4.4) 192 3 (1.6) 0.07
Normal 413 (82.4) 171 (89.1)
Long 66 (13.2) 18 (9.4)
Gynaecological diseases 522 17 (3.3) 209 4 (1.9) 0.46
Previous abdominal operations 526 51 (9.7) 209 14 (6.7) 0.25
HIV seropositive 447 33 (7.4) 153 1 (0.7) <0.001���
Malaria during study 527 59 (11.2) 209 26 (12.4) 0.61
Urogenital infections during the study 527 150 (28.5) 209 19 (9.1) <0.001���
Hgb at enrolment (g/dL) <9 527 14 (2.7) 209 5 (2.4) 1
9–11.9 177 (33.6) 70 (33.5)
Contraception before study 527 412 (78.2) 209 174 (83.3) 0.13
Hormonal contraception before study 527 346 (65.7) 209 149 (71.3) 0.16
Traditional contraception before study 527 205 (38.9) 209 73 (34.9) 0.35
Condom usage before study 527 136 (25.8) 209 42 (20.1) 0.11
Termination of hormonal contraception <3 months 527 27 (5.1) 209 31 (14.8) <0.001���
3–6 months 42 (8.0) 26 (12.4)
6–12 months 55 (10.4) 22 (10.5)
>12 months 149 (28.3) 53 (25.4)
Never used 181 (34.3) 60 (24.9)
Used. Term. date unknown 73 (13.9) 17 (28.7)
(Continued)
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grouped UTI, suspected STI/RTI, and candidiasis as urogenital infections. In support of this
approach, an explorative analysis of the individually subgroups (STI/RTI, UTI, or vaginal can-
didiasis) suggested the three conditions were all negatively correlated with fertility, although
Table 2. (Continued)
Characteristic Interval N total N (%)
Non preg.
N total N (%)
Pregnant
p-value
Termination of traditional contraception <3 months 527 3 (0.6) 209 4 (1.9) 0.03�
3–6 months 7 (1.3) 4 (1.9)
6–12 months 12 (2.3) 3 (1.4)
>12 months 37 (7.0) 4 (1.9)
Never used 322 (61.1) 136 (65.1)
Used, Term. date unknown 21 (4.0) 13 (6.2)
Still using 125 (23.7) 45 (21.5)
Current use of contraception 527 161 (30.6) 209 51 (24.4) 0.10
N is the total number of women with answers available in each categories, N (%) not-pregnant is the number and percent of women in the subcategory that did not
become pregnant in 180 days, N (%) pregnant is the number and percent of women in the subcategories that became pregnant within 180 days. p-value for each group
found with Fisher´s Exact test.
� p-value < 0.05
�� p-value < 0.01
��� < 0.001,.
https://doi.org/10.1371/journal.pone.0210421.t002
Table 3. Multivariate model for factors significantly affecting change of conceiving.
Characteristic Interval OR 95%CI p-value
Age 18–25 Ref
re
25–30 0.74 0.44–1.2 0.23
30–35 0.45 0.26–0.77 0.004��
35–40 0.43 0.26–0.71 0.001��
Partner status No partner Ref
Living with partner 3.55 1.84–7.39 <0.001���
Partner—not living together 1.91 0.83–4.53 0.13
Urogenital infection No Ref
Yes 0.21 0.11–0.36 <0.001���
House roof Corrugated iron Ref
Not -corrugated iron 1.56 1.04–2.33 0.04�
Terminated hormonal contraception Never used Ref
<3 months 2.86 1.45–5.70 0.002��
3–6 months 1.51 0.78–2.89 0.21
6–12 months 1.27 0.64–2.46 0.49
> 12 months 1.11 0.67–1.84 0.70
Used, term date unknown 0.91 0.45–1.76 0.78
Logistic regression model predicting pregnancy probability from explanatory variables selected from a larger set via backwards step-by step elimination. OR with 95%-
CI shown for the different subgroups and Wald test p-values comparing the subgroup with the reference subgroup.
� p-value < 0.05
�� p-value < 0.01
��� p-value < 0.001. A similar analysis without grouping of continuous variables can be seen in the supplementary material (S3 Table).
https://doi.org/10.1371/journal.pone.0210421.t003
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this was only stastistically significant for UTI and vaginal candidiasis. To our knowledge previ-
ous studies have not shown an association between a single UTI or a candida infection and
reduced fertility. Our findings might be explained by clinical misclassification, and it is possi-
ble that some of the diagnosed UTI and/or vaginal candidiasis were actually STIs. UTI might
have been over-diagnosed since contamination of urine with vaginal secretion would lead to
positive urine strips for leucocytes, protein or blood, and mid-stream urine sampling or disin-
fection of external genitals was not undertaken routinely. This would have been preferable in
order to distinguish between the diagnoses [37].
The relative contribution of STI/RTI, vaginal candidiasis, and UTI to reduced conception
rates in our setting obviously requires further research, but a change towards more intensive
treatment of both suspected STI´s and urogenital infections in areas with limited diagnostic
possibilities could be warranted. These conditions are easily treated with antibiotics and anti-
fungals. In addition, better diagnostic tools for chlamydia, gonococcus, and trichomoniasis are
urgently needed, since there are no point of care tests at the moment [38] and syndromic treat-
ment has previously been shown to have low sensitivity [39].
The effect of age, partner status, socioeconomic status, and contraception
As found by Crawford et al [18], age was also statistically significantly associated with reduced
fertility in our study. Living with a partner and having a lower socioeconomic status (ranked
by type of roof) also exhibited the expected association with increased chances of becoming
pregnant. Although use of traditional family planning was not significantly associated with
reduced fertility, low socioeconomic status might reflect a poorer pregnancy control based on
traditional contraception, as suggested by Ayele et al [40].
Among the women who conceived, 24% used condoms and/or traditional family planning.
Others have also reported high rates of conceiving despite usage of condoms and traditional
family planning [41]. The high reported usage among women who conceived might indicate
that reported use is not equal to actual or constant use. Irregular use of condoms is of particu-
lar concern considering the high prevalence of STI observed.
Compared to women with no previous use of hormonal contraceptives, women who
recently terminated usage were more likely to conceive, whereas women who terminated hor-
monal contraceptives >90 days ago were not. Studies on hormonal contraception and fertility
have not consistently shown any negative effect on fertility [42] and no study has—to the best
of our knowledge—showed increased fertility due to previous use of hormones. The explana-
tion for the observed increase in fertility in the group could be that the women who recently
stopped using hormonal contraceptives were actively trying to become pregnant with a higher
frequency and timing of sexual intercourse. In contrast, women who had terminated the usage
of hormone contraception for a long time and still had not become pregnant before enrolment
into our study actually represented a less fertile group.
The effect of other health factors
Other health factors investigated in this study including malaria, diabetes, anaemia, and hyper-
tension did not show any statistically significant effect on the chances of conceiving in the mul-
tivariate model. In contrast to findings in other studies, gynaecological diseases such as
fibromas did not show any association with reduced fertility either [43]. This may be due to
the low number of women diagnosed with fibroma in our study. In the univariate analysis
HIV positive women had a significantly lower chance of conceiving. The total number of HIV
positive women in the study was 34 and only one of them became pregnant. The data was
therefore too limited to be included in the multivariate analysis. The results, however, show a
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strong tendency of lower fertility in HIV infected women, which is in accordance with previ-
ous reports [44]. Anaemia has in smaller clinical studies, and in animal studies been suspected
to reduce fertility [45, 46]. It was not possible to demonstrate this association in the present
study, also not when adjusting for changes in Hgb concentration during follow-up.
Strengths and weaknesses
The follow-up period was not identical for all women. The first women enrolled could poten-
tially be followed for more than 1½ year (July 2014 –March 2016), whereas women enrolled in
December 2015 could only be followed for three months. In order to address this, we only
included women who were followed for at least 180 days and only included pregnancies that
occurred within this period, which meant a considerably reduced sample size. However, the
robustness of our approach was confirmed by generating both a 90 days and a 360 days model
yielding similar results as obtained with 180 day follow-up.
The present study was part of the FOETALforNCD project, aiming to elucidate the role of
maternal anaemia in the development of epigenetic changes in the new-born with possible
consequences for the later development of life-style diseases [47, 48]. FOETALforNCD was
not designed as a fertility study and inclusion criteria were based on a likelihood of becoming
pregnant. Women using traditional contraceptive methods and condoms have a considerable
chance of becoming pregnant within a year [41] and were therefore enrolled. Furthermore, in
order to avoid disclosing whether the woman had a partner, partner status was not used as an
inclusion criterion, and only limited information on the partner was collected after enrolment.
The partner could therefore not be evaluated. Information on sexual activity and the desire to
conceive was also not available. This could have introduced bias and the results presented here
can therefore not be immediately applied to other populations. However, our rigorous classifi-
cation of preconceptional status using both UPT and gestational age estimated with ultrasound
strengthens our study and gives an indication of important factors associated with chances of
conceiving in the area. Furthermore, we provide an indication of how many women can be
expected to become pregnant within the defined time period, which can aid in planning,
designing and executing future preconception and pregnancy studies–and hopefully also aid
women (and partners) wanting to plan their families.
Conclusion
Urogenital infection was the major health factor associated with a reduced chance of conceiv-
ing. Considering the availability of effective treatment options for these diseases, public health
authorities in Tanzania should increase awareness of diagnostic tools in poor settings in order
to improve chances of getting pregnant when desired.
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